Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 434825, 14 pages
http://dx.doi.org/10.1155/2015/434825
Research Article

Thiopurines Induce Oxidative Stress in T-Lymphocytes: A Proteomic Approach

1Institute of Clinical Chemistry/UMG Laboratories, University Medical Centre Goettingen, 37075 Goettingen, Germany
2Medical Laboratories, 28357 Bremen, Germany

Received 19 June 2014; Revised 6 September 2014; Accepted 9 September 2014

Academic Editor: Yung-Hsiang Chen

Copyright © 2015 Misbah Misdaq et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Dubinsky, “Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety,” Clinical Gastroenterology and Hepatology, vol. 2, no. 9, pp. 731–743, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. Cara, A. S. Pena, M. Sans et al., “Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice,” Medical Science Monitor, vol. 10, no. 11, pp. RA247–RA254, 2004. View at Google Scholar · View at Scopus
  3. L. Lennard, “The clinical pharmacology of 6-mercaptopurine,” European Journal of Clinical Pharmacology, vol. 43, no. 4, pp. 329–339, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Karran, “Thiopurines, DNA damage, DNA repair and therapy-related cancer,” British Medical Bulletin, vol. 79–80, no. 1, pp. 153–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. W. K. Lee, H. G. Sun, T. Zang, B. Ju-Kim, J. F. Alfaro, and Z. S. Zhou, “Enzyme-catalyzed transfer of a ketone group from an S-adenosylmethionine analogue: a tool for the functional analysis of methyltransferases,” Journal of the American Chemical Society, vol. 132, no. 11, pp. 3642–3643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Weinshilboum and S. L. Sladek, “Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity,” American Journal of Human Genetics, vol. 32, no. 5, pp. 651–662, 1980. View at Google Scholar · View at Scopus
  7. R. B. Gearry and M. L. Barclay, “Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease,” Journal of Gastroenterology and Hepatology, vol. 20, no. 8, pp. 1149–1157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Wang, L. Pelleymounter, R. Weinshilboum et al., “Very important pharmacogene summary: thiopurine S-methyltransferase,” Pharmacogenetics and Genomics, vol. 20, no. 6, pp. 401–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. R. Lichtenstein, M. T. Abreu, R. Cohen, and W. Tremaine, “American gastroenterological association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease,” Gastroenterology, vol. 130, no. 3, pp. 940–987, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-F. Colombel, N. Ferrari, H. Debuysere et al., “Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy,” Gastroenterology, vol. 118, no. 6, pp. 1025–1030, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. T. C. D. R. Ribeiro, L. A. Chebli, P. D. Gaburri, and J. M. F. Chebli, “Azathioprine in ulcerative colitis: why, when, how and how long to use it,” Drug Development Research, vol. 72, no. 8, pp. 733–738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. W. L. Leong, R. B. Gearry, and M. P. Sparrow, “Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol,” Expert Opinion on Drug Safety, vol. 7, no. 5, pp. 607–616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Tapner, B. E. Jones, W. M. Wu, and G. C. Farrell, “Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury,” Journal of Hepatology, vol. 40, no. 3, pp. 454–463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Menor, M. D. Fernández-Moreno, J. A. Fueyo et al., “Azathioprine acts upon rat hepatocyte mitochondria and stress-activated protein kinases leading to necrosis: protective role of N-acetyl-L-cysteine,” Journal of Pharmacology and Experimental Therapeutics, vol. 311, no. 2, pp. 668–676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Ka, S. Shrivastava, M. Shrivastava, N. Dhankhar, and S. Kumar, “Azathioprine induce TCA dysfunction due to oxidative stress and protective effect of Qucertin in rat hepatocytes,” International Journal of Biomedical and Pharmaceutical Sciences, vol. 2, no. 3, pp. 1297–1302, 2011. View at Google Scholar
  16. I. Daehn, R. Brem, E. Barkauskaite, and P. Karran, “6-thioguanine damages mitochondrial DNA and causes mitochondrial dysfunction in human cells,” FEBS Letters, vol. 585, no. 24, pp. 3941–3946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Zhang, L. Fu, and Y. Wang, “6-Thioguanine induces mitochondrial dysfunction and oxidative dna damage in acute lymphoblastic leukemia cells,” Molecular and Cellular Proteomics, vol. 12, no. 12, pp. 3803–3811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Zaza, M. Cheok, W. Yang et al., “Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment,” Blood, vol. 106, no. 5, pp. 1778–1785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. H. L. Kim, E. J. Lee, and H. N. Kim, “Gene expression profiling of 6-MP (6-mercaptopurine) in liver,” Genomics & Informatics, vol. 4, no. 1, pp. 16–22, 2006. View at Google Scholar
  20. M. Misdaq, R. Andag, M. Oellerich, A. R. Asif, and N. von Ahsen, “Establishment of thiopurine s-methyltransferase gene knockdown in Jurkat T-lymphocytes: an in vitro model of TPMT polymorphism,” Therapeutic Drug Monitoring, vol. 34, no. 5, pp. 584–592, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Görg, C. Obermaier, G. Boguth et al., “The current state of two-dimensional electrophoresis with immobilized pH gradients,” Electrophoresis, vol. 21, no. 6, pp. 1037–1053, 2000. View at Google Scholar
  22. S. Luhn, M. Berth, M. Hecker, and J. Bernhard, “Using standard positions and image fusion to create proteome maps from collections of two-dimensional gel electrophoresis images,” Proteomics, vol. 3, no. 7, pp. 1117–1127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Shevchenko, M. Wilm, O. Vorm, and M. Mann, “Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels,” Analytical Chemistry, vol. 68, no. 5, pp. 850–858, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. A. R. Asif, M. Oellerich, V. W. Amstrong, B. Riemenschneider, M. Monod, and U. Reichard, “Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens,” Journal of Proteome Research, vol. 5, no. 4, pp. 954–962, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. L. Tatusov, N. D. Fedorova, J. D. Jackson et al., “The COG database: an updated vesion includes eukaryotes,” BMC Bioinformatics, vol. 4, article 41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Buranrat, A. Prawan, U. Kukongviriyapan, S. Kongpetch, and V. Kukongviriyapan, “Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells,” World Journal of Gastroenterology, vol. 16, no. 19, pp. 2362–2370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. B. W. Bernstein and J. R. Bamburg, “ADF/cofilin: a functional node in cell biology,” Trends in Cell Biology, vol. 20, no. 4, pp. 187–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Lowe and L. S. Itzhaki, “Biophysical characterisation of the small ankyrin repeat protein myotrophin,” Journal of Molecular Biology, vol. 365, no. 4, pp. 1245–1255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Wang, G.-L. Zhou, S. Vedantam, P. Li, and J. Field, “Mitochondrial shuttling of CAP1 promotes actin- and cofilin-dependent apoptosis,” Journal of Cell Science, vol. 121, no. 17, pp. 2913–2920, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-S. Kim, T. Y. Huang, and G. M. Bokoch, “Reactive oxygen species regulate a slingshot-cofilin activation pathway,” Molecular Biology of the Cell, vol. 20, no. 11, pp. 2650–2660, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. K. I. Brackley and J. Grantham, “Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation,” Cell Stress and Chaperones, vol. 14, no. 1, pp. 23–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G.-S. Hong, R. Heun, F. Jessen et al., “Gene variations in GSTM3 are a risk factor for Alzheimer's disease,” Neurobiology of Aging, vol. 30, no. 5, pp. 691–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-W. Lo and F. Ali-Osman, “Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance,” Current Opinion in Pharmacology, vol. 7, no. 4, pp. 367–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Stocco, S. Martelossi, A. Barabino et al., “Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 13, no. 1, pp. 57–64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. B. A. Stanley, V. Sivakumaran, S. Shi et al., “Thioredoxin reductase-2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria,” The Journal of Biological Chemistry, vol. 286, no. 38, pp. 33669–33677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. D. C. Angeles, B.-H. Gan, L. Onstead et al., “Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death,” Human Mutation, vol. 32, no. 12, pp. 1390–1397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Ullmann, A. M. Wiencierz, C. Müller et al., “A high-throughput reporter gene assay to prove the ability of natural compounds to modulate glutathione peroxidase, superoxide dismutase and catalase gene promoters in V79 cells,” Free Radical Research, vol. 42, no. 8, pp. 746–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. M. Troy and M. L. Shelanski, “Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 14, pp. 6384–6387, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. M. T. Lin and M. F. Beal, “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases,” Nature, vol. 443, no. 7113, pp. 787–795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. J. M. Flynn and S. Melovn, “SOD2 in mitochondrial dysfunction and neurodegeneration,” Free Radical Biology and Medicine, vol. 62, pp. 4–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S. R. Pfeffer and D. Aivazian, “Targeting Rab GTPases to distinct membrane compartments,” Nature Reviews Molecular Cell Biology, vol. 5, no. 11, pp. 886–896, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Navon and A. Ciechanover, “The 26 S proteasome: from basic mechanisms to drug targeting,” The Journal of Biological Chemistry, vol. 284, no. 49, pp. 33713–33718, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Kikuchi, Y. Iwafune, T. Akiyama et al., “Co- and post-translational modifications of the 26S proteasome in yeast,” Proteomics, vol. 10, no. 15, pp. 2769–2779, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. E. J. Tran and S. R. Wente, “Dynamic nuclear pore complexes: life on the edge,” Cell, vol. 125, no. 6, pp. 1041–1053, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. M. W. Hetzer, T. C. Walther, and I. W. Mattaj, “Pushing the envelope: structure, function, and dynamics of the nuclear periphery,” Annual Review of Cell and Developmental Biology, vol. 21, pp. 347–380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. C. I. Rubin and G. F. Atweh, “The role of stathmin in the regulation of the cell cycle,” Journal of Cellular Biochemistry, vol. 93, no. 2, pp. 242–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Marzano, S. Santini, C. Rossi et al., “Proteomic profiling of ATM kinase proficient and deficient cell lines upon blockage of proteasome activity,” Journal of Proteomics, vol. 75, no. 15, pp. 4632–4646, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. J. R. Monaghan, J. A. Walker, R. B. Page, S. Putta, C. K. Beachy, and S. R. Voss, “Early gene expression during natural spinal cord regeneration in the salamander Ambystoma mexicanum,” Journal of Neurochemistry, vol. 101, no. 1, pp. 27–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. L. Circu and T. Y. Aw, “Reactive oxygen species, cellular redox systems, and apoptosis,” Free Radical Biology & Medicine, vol. 48, no. 6, pp. 749–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Zou, Z. Ding, and P. Roy, “Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation,” Journal of Cellular Physiology, vol. 223, no. 3, pp. 623–629, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A. C. Uetrecht and J. E. Bear, “Coronins: the return of the crown,” Trends in Cell Biology, vol. 16, no. 8, pp. 421–426, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Cai, N. Holoweckyj, M. D. Schaller, and J. E. Bear, “Phosphorylation of coronin 1B by protein kinase C regulates interaction with Arp2/3 and cell motility,” The Journal of Biological Chemistry, vol. 280, no. 36, pp. 31913–31923, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. S. B. Padrick, L. K. Doolittle, C. A. Brautigam, D. S. King, and M. K. Rosen, “Arp2/3 complex is bound and activated by two WASP proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 33, pp. E472–E479, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. M. R. Clarkson, M. Murphy, S. Gupta et al., “High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly,” Journal of Biological Chemistry, vol. 277, no. 12, pp. 9707–9712, 2002. View at Google Scholar
  55. R. Brem and P. Karran, “Oxidation-mediated DNA cross-linking contributes to the toxicity of 6-thioguanine in human cells,” Cancer Research, vol. 72, no. 18, pp. 4787–4795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. S. M. Govani and P. D. Higgins, “Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD,” Journal of Crohn's and Colitis, vol. 4, no. 4, pp. 444–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Piel, S. Vaidya, D. Lancaster, M. Taj, and K. Pritchard-Jones, “Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia,” British Journal of Haematology, vol. 125, no. 3, pp. 410–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Ivernizzi, S. Bernuzzi, D. Ciani, and E. Ascari, “Silymarine during maintenance therapy of acute promyelocytic leukemia,” Haematologica, vol. 78, no. 5, pp. 340–341, 1993. View at Google Scholar · View at Scopus
  59. A. C. Rego and C. R. Oliveira, “Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases,” Neurochemical Research, vol. 28, no. 10, pp. 1563–1574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Mougiakakos, C. C. Johansson, R. Jitschin, M. Böttcher, and R. Kiessling, “Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress,” Blood, vol. 117, no. 3, pp. 857–861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. M. C. Velarde, J. M. Flynn, N. U. Day, S. Melov, and J. Campisi, “Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin,” Aging, vol. 4, no. 1, pp. 3–12, 2012. View at Google Scholar · View at Scopus
  62. Z. Liu, H. Lu, H. Shi et al., “PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells,” Cancer Research, vol. 65, no. 5, pp. 1647–1654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. X. Deng, F. Gao, and W. S. May Jr., “Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS,” Blood, vol. 102, no. 9, pp. 3179–3185, 2003. View at Publisher · View at Google Scholar · View at Scopus